Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients

Introduction: Survival of ALK-rearranged NSCLC patients has dramatically improved by the use of multiple ALK-tyrosine kinase inhibitors (ALK-TKI). However, still little is known about the impact of drug sequencing and clinical features on survival in a real-world setting. Methods: Patients with stag...

Descripción completa

Detalles Bibliográficos
Autores principales: Britschgi, Christian, Addeo, Alfredo, Rechsteiner, Markus, Delaloye, Raphaël, Früh, Martin, Metro, Giulio, Banini, Marco, Gautschi, Oliver, Rothschild, Sacha I., Wild, Peter J., Banna, Giuseppe L., Curioni-Fontecedro, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472246/
https://www.ncbi.nlm.nih.gov/pubmed/32974130
http://dx.doi.org/10.3389/fonc.2020.01299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472246/
https://www.ncbi.nlm.nih.gov/pubmed/32974130
http://dx.doi.org/10.3389/fonc.2020.01299

Ejemplares similares